# OnCo record robert-motzer (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/robert-motzer/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "robert-motzer" ;
  schema:name "Robert J. Motzer"@en ;
  schema:description "The kidney cancer trialist behind sunitinib, CheckMate 214 and CLEAR, three shifts in first-line standard of care."@en ;
  schema:url <https://onco.cc/people/robert-motzer/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Motzer%20RJ%5BAuthor%5D%20renal%20cell> ;
  onco:tag "rcc", "trialist" ;
  schema:jobTitle "Jack and Dorothy Byrne Chair in Clinical Oncology, Memorial Sloan Kettering Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0001-6925-2327> ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/ctla4/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/checkmate-214/>, <https://onco.cc/trials/clear/>, <https://onco.cc/trials/checkmate-9er/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-clear-nejm-2021/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .